Search research articles
Contact Us
Filters
Showing results (21-30 of 60) with videos related to
Page
of 6
Sort By:
Lancet (London, England)
|
January 2, 1993
Enhanced in-vitro platelet aggregability during postprandial hyperlipidaemia
H Sinzinger, C Pirich, P Fitscha, et al.
Wiener Klinische Wochenschrift
|
January 1, 1992
Reversible dyslipoproteinemia in patients with malaria is associated with a shortened prostaglandin I2 half-life in plasma
Y Efthimiou, C Pirich, J Stomatopoulos, et al.
Atherosclerosis
|
October 25, 1996
Decreased susceptibility of low-density lipoproteins to in-vitro oxidation after dextran-sulfate LDL-apheresis treatment
N Leitinger, C Pirich, I Blazek, et al.
Thrombosis Research
|
June 1, 1997
Effect of isradipine on in-vivo platelet function
J O'Grady, H Kritz, P Schmid, et al.
Clinical Endocrinology
|
March 12, 2008
Long-term prognosis of medullary thyroid carcinoma
G Rendl, M Manzl, W Hitzl, et al.
Thrombosis Research
|
January 15, 1996
Apolipoprotein A and biological half-life of prostaglandin I2 in HIV-1 infection
C Pirich, Y Efthimiou, J O'Grady, et al.
Scandinavian Journal of Medicine & Science in Sports
|
June 18, 2011
Glucose homeostasis and cardiovascular disease biomarkers in older alpine skiers
F Dela, D Niederseer, W Patsch, et al.
Nuklearmedizin. Nuclear Medicine
|
December 12, 2003
[Radiation doses deriving from patients treated with (166)Ho-ferric hydroxide]
J Preitfellner, C Pirich, P John, et al.
BMC Medical Imaging
|
February 26, 2020
The impact of 18F-FDOPA-PET/MRI image fusion in detecting liver metastasis in patients with neuroendocrine tumors of the gastrointestinal tract
O Barachini, R Bernt, S Mirzaei, et al.
Blood Pressure. Supplement
|
January 1, 1994
Isradipine increases platelet--low-density lipoprotein binding: evidence from ex-vivo studies in humans
P Schmid, C Pirich, P Fitscha, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 60) with videos related to
Sort By:
Page
of 6
Lancet (London, England)
|
January 2, 1993
Enhanced in-vitro platelet aggregability during postprandial hyperlipidaemia
H Sinzinger, C Pirich, P Fitscha, et al.
Wiener Klinische Wochenschrift
|
January 1, 1992
Reversible dyslipoproteinemia in patients with malaria is associated with a shortened prostaglandin I2 half-life in plasma
Y Efthimiou, C Pirich, J Stomatopoulos, et al.
Atherosclerosis
|
October 25, 1996
Decreased susceptibility of low-density lipoproteins to in-vitro oxidation after dextran-sulfate LDL-apheresis treatment
N Leitinger, C Pirich, I Blazek, et al.
Thrombosis Research
|
June 1, 1997
Effect of isradipine on in-vivo platelet function
J O'Grady, H Kritz, P Schmid, et al.
Clinical Endocrinology
|
March 12, 2008
Long-term prognosis of medullary thyroid carcinoma
G Rendl, M Manzl, W Hitzl, et al.
Thrombosis Research
|
January 15, 1996
Apolipoprotein A and biological half-life of prostaglandin I2 in HIV-1 infection
C Pirich, Y Efthimiou, J O'Grady, et al.
Scandinavian Journal of Medicine & Science in Sports
|
June 18, 2011
Glucose homeostasis and cardiovascular disease biomarkers in older alpine skiers
F Dela, D Niederseer, W Patsch, et al.
Nuklearmedizin. Nuclear Medicine
|
December 12, 2003
[Radiation doses deriving from patients treated with (166)Ho-ferric hydroxide]
J Preitfellner, C Pirich, P John, et al.
BMC Medical Imaging
|
February 26, 2020
The impact of 18F-FDOPA-PET/MRI image fusion in detecting liver metastasis in patients with neuroendocrine tumors of the gastrointestinal tract
O Barachini, R Bernt, S Mirzaei, et al.
Blood Pressure. Supplement
|
January 1, 1994
Isradipine increases platelet--low-density lipoprotein binding: evidence from ex-vivo studies in humans
P Schmid, C Pirich, P Fitscha, et al.
Page
of 6